Dr Chris Lamb
Chris is Chief Investigator of the IBD-RESPONSE study. He is a Senior Lecturer within the Translational & Clinical Research Institute at Newcastle University and an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals specialising in management of inflammatory bowel disease. Newcastle University profileNHS profile@DrChrisLamb
Chris is a group lead with a research laboratory team studying molecular mucosal immunology, the gut microbiome, drug discovery and precision medicine in Crohn's disease and ulcerative colitis.
Dr Chris Stewart
Chris is a Wellcome Trust Sir Henry Dale Fellow & Lister Institute Prize Fellow within the Translational & Clinical Research Institute at Newcastle University. Find out more@CJStewart7
Chris leads a research group focused on multi-omic computational and experimental approaches to study microbial-host interaction in the gut, to determine mechanisms of health and gastrointestinal diseases.
Dr Ally Speight
Ally is a Consultant Gastroenterologist at the Newcastle upon Tyne Hospitals NHS Foundation Trust and Associate Clinical Lecturer within the Translational & Clinical Research Institute at Newcastle University.Find out more@Drallyspeight
Ally's clinical and research interests include therapeutics in inflammatory bowel disease.
Dr Nicola Wyatt
Nicola is an Academic Clinical Fellow in gastroenterology, with an interest in inflammatory bowel disease. She is an Associate PI for IBD-RESPONSE.Find out more@wyatt_nic
To find out more about the Associate PI scheme, follow the link below.
Newcastle Clinical Trials Unit (NCTU)
Dr Naomi McGregor
Senior Trial Manager
Naomi is the Senior Trial Manager for IBD-RESPONSE and provides oversight and support to the study management group ensuring that the study is conducted in line with sponsor, regulatory and research governance requirements
Dr Dean Allerton
Dean is a Trial Co-Manager, co-managing the IBD-RESPONSE study. Dean works closely with site staff to respond to queries concerning any aspects of the study.
Dr Victoria Hildreth
Victoria is Trial Co-Manager for IBD-RESPONSE study, making sure the study is compliant with the study protocol and international standards of Good Clinical Practice (GCP).
Kusalta is a data manager for IBD-RESPONSE and has background experience in commercial project management.
Clinical Trial Administrator
Kath is a Clinical Trial Administrator for IBD-RESPONSE.
Clinical Trial Administrator
Sarah has a background in Administration and Events Management and now the Clinical Trials Administrator for IBD-RESPONSE.
IBD-RESPONSE Laboratory and Analytical Team
Jen completed her Master of Research Degree at Newcastle University, in Cancer Studies, and has been working as a Laboratory Technical Specialist working on a variety of exciting projects, including IBD-RESPONSE.
Dr Hannah Fuller
Hannah completed her PhD in drug-toxicity in 2021, and has since began the role as a Technical Specialist for IBD-RESPONSE, setting up the lab for receipt and processing of patient samples, and supporting different research projects.